Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan and Nebivolol/Valsartan in Hypertensive Subjects With Left Ventricular Hypertrophy
NCT03180593Phase 4Completed
- Sponsor
- Trinity Hypertension & Metabolic Research Institute
- Start
- Feb 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nebivolol + valsartan in hypertension (HTN), left ventricular hypertrophy (LVH), sponsored by Trinity Hypertension & Metabolic Research Institute. Started Feb 2017; status: completed.
02
Drugs
nebivolol + valsartan
03
Conditions
hypertension (HTN)left ventricular hypertrophy (LVH)
Beyond the preview
Go deeper on NCT03180593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03180593.